These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21130495)

  • 1. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
    Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
    Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
    Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia.
    Sivina M; Hartmann E; Vasyutina E; Boucas JM; Breuer A; Keating MJ; Wierda WG; Rosenwald A; Herling M; Burger JA
    Leukemia; 2012 Aug; 26(8):1812-20. PubMed ID: 22460735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
    Visone R; Rassenti LZ; Veronese A; Taccioli C; Costinean S; Aguda BD; Volinia S; Ferracin M; Palatini J; Balatti V; Alder H; Negrini M; Kipps TJ; Croce CM
    Blood; 2009 Oct; 114(18):3872-9. PubMed ID: 19717645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
    Hanlon K; Rudin CE; Harries LW
    PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia.
    Farahat NMG; Elkaffash DMNED; Alghandour AH; Swelem RS; Abo El-Wafa RAH
    Indian J Hematol Blood Transfus; 2019 Jan; 35(1):89-99. PubMed ID: 30828154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-15 and miR-16 induce apoptosis by targeting BCL2.
    Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
    Bresin A; Callegari E; D'Abundo L; Cattani C; Bassi C; Zagatti B; Narducci MG; Caprini E; Pekarsky Y; Croce CM; Sabbioni S; Russo G; Negrini M
    Oncotarget; 2015 Aug; 6(23):19807-18. PubMed ID: 26090867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.
    Karan-Djurasevic T; Palibrk V; Zukic B; Spasovski V; Glumac I; Colovic M; Colovic N; Jurisic V; Scorilas A; Pavlovic S; Tosic N
    Med Oncol; 2013 Mar; 30(1):405. PubMed ID: 23292833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
    Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
    J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
    Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
    Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
    Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
    Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.
    Li S; Moffett HF; Lu J; Werner L; Zhang H; Ritz J; Neuberg D; Wucherpfennig KW; Brown JR; Novina CD
    PLoS One; 2011 Mar; 6(3):e16956. PubMed ID: 21408091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
    Calin GA; Pekarsky Y; Croce CM
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.
    Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B
    PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
    Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY
    Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.